Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · Real-Time Price · USD
25.85
-0.38 (-1.45%)
Nov 21, 2024, 12:04 PM EST - Market open
Zai Lab Employees
Zai Lab had 2,175 employees as of December 31, 2023. The number of employees increased by 139 or 6.83% compared to the previous year.
Employees
2,175
Change (1Y)
139
Growth (1Y)
6.83%
Revenue / Employee
$163,562
Profits / Employee
-$124,528
Market Cap
2.54B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Ardent Health Partners | 23,000 |
QuidelOrtho | 7,100 |
iRhythm Technologies | 2,000 |
Privia Health Group | 1,102 |
Twist Bioscience | 919 |
Catalyst Pharmaceuticals | 167 |
Scholar Rock Holding | 150 |
Protagonist Therapeutics | 112 |
ZLAB News
- 8 hours ago - Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam) - Business Wire
- 3 days ago - Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares - Business Wire
- 6 days ago - Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire
- 7 days ago - Zai Lab Announces Proposed Public Offering of American Depositary Shares - Business Wire
- 9 days ago - Zai Lab Limited (ZLAB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire
- 10 days ago - Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Business Wire
- 23 days ago - Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China - Business Wire